Effects of alternate-day prednisone therapy on respiratory function in myasthenia gravis.

AUTOR(ES)

Newball, H H

RESUMO

To determine the effects of alternate-day prednisone therapy on respiratory function in myasthenia gravis, eight patients were evaluated during "days on" and "days off" prednisone. The patients were treated with long-term (up to three years), high-single-dose, alternate-day oral prednisone. After patients had been controlled with alternate-day prednisone they had no episodes of acute respiratory insufficiency or myasthenic crises. Although a small reduction in respiratory function during the day off prednisone was seen in some patients, the change was not statistically significant for the group and was probably physiologically unimportant in most patients. The data indicate that in myasthenic patients who have no underlying lung disease respiratory function is not significantly compromised by administering the prednisone on alternate days.

Documentos Relacionados

• Alternate-day prednisone therapy and human lymphocyte subpopulations.
• Alternate-day steroid regimen in the treatment of ocular disease.
• Effect of single-dose alternate-day corticosteroid administration on hypothalamo-pituitary-adrenal function in patients with rheumatoid disease.
• Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function.
• Lymphocyte function in myasthenia gravis.